These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibiotic use in the emergency department. III. The quinolones, new beta lactams, beta lactam combination agents, and miscellaneous antibiotics. Schmidt J; Pollack CV J Emerg Med; 1996; 14(4):483-96. PubMed ID: 8842923 [TBL] [Abstract][Full Text] [Related]
3. [Recommendations for the indication-justified application of antibiotics. 2. Aminoglycosides, quinolones, tetracyclines]. Briedigkeit H; Halle E Z Arztl Fortbild (Jena); 1991 Aug; 85(16):743-6. PubMed ID: 1949996 [No Abstract] [Full Text] [Related]
4. [New quinolones for the treatment of community-acquired pneumonia--contra]. Egger M Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860 [No Abstract] [Full Text] [Related]
5. [Contribution of experimental models to the treatment of respiratory tract infections]. Chidiac C; Nelson S; Summer WR; Mouton Y Pathol Biol (Paris); 1989 Jun; 37(6):754-8. PubMed ID: 2780114 [TBL] [Abstract][Full Text] [Related]
6. Beta-lactam antibiotic and beta-lactamase inhibitor combinations. Lee NL; Yuen KY; Kumana CR JAMA; 2001 Jan 24-31; 285(4):386-8. PubMed ID: 11242403 [No Abstract] [Full Text] [Related]
7. Efficacy of co-amoxiclav compared with other beta-lactams, quinolones, tetracyclines and erythromycin against an experimental Chlamydia trachomatis respiratory infection. Beale AS J Antimicrob Chemother; 1993 Nov; 32(5):781-2. PubMed ID: 8125847 [No Abstract] [Full Text] [Related]
8. Antibiotic studies in pneumonia. Pitfalls in interpretation and suggested soluions. Chow JW; Yu VL Chest; 1989 Sep; 96(3):453-6. PubMed ID: 2491417 [No Abstract] [Full Text] [Related]
9. Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia. Ramirez JA Ann Pharmacother; 1998 Jan; 32(1):S22-6. PubMed ID: 9475836 [TBL] [Abstract][Full Text] [Related]
10. [The antibacterial therapy of infectious lung lesions]. Martsinovskiĭ VIu; Sil'vestrov VP; Semin SN Ter Arkh; 1990; 62(9):8-15. PubMed ID: 2281414 [No Abstract] [Full Text] [Related]
11. The John Barnwell Lecture. The chemotherapy of bacterial respiratory infections. Crofton J Am Rev Respir Dis; 1970 Jun; 101(6):841-59. PubMed ID: 4914352 [No Abstract] [Full Text] [Related]
16. Bacterial challenges and evolving antibacterial drug strategy. Watt B; Collee JG Postgrad Med J; 1992 Jan; 68(795):6-21. PubMed ID: 1561196 [No Abstract] [Full Text] [Related]
17. Roundtable discussion of antibiotic therapy in surgical infections. Barie PS; Coppa G; Cryer HG; Fry DE; Lee PC; Martens MG; Nichols RL; O'Leary JP; Rapp RP; Sirinek KR; Smith DW; Wilson SE Surg Infect (Larchmt); 2000; 1(1):79-89. PubMed ID: 12594913 [No Abstract] [Full Text] [Related]
18. β-Lactams against Tuberculosis--New Trick for an Old Dog? Diacon AH; van der Merwe L; Barnard M; von Groote-Bidlingmaier F; Lange C; García-Basteiro AL; Sevene E; Ballell L; Barros-Aguirre D N Engl J Med; 2016 Jul; 375(4):393-4. PubMed ID: 27433841 [No Abstract] [Full Text] [Related]
19. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574 [TBL] [Abstract][Full Text] [Related]